Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Inc’s and Roche’s newly authorized COVID-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.
The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.
Watch: Hundreds of cars line up to enter Bahrain at King Fahd causeway as it reopensHundreds of cars lined up the King Fahd causeway to enter Bahrain as thousands of citizens and residents of Saudi Arabia are expected to cross the ... Gulf
Bahrain, Kuwait strongly condemn Lebanon’s FM statements on Saudi Arabia and GCCThe Ministries of Foreign Affairs of Kuwait and Bahrain expressed their strong condemnation of the offensive statements made by the Minister of ... Gulf
Bahrain restricts access for unvaccinated as COVID-19 cases spikeBahrain said on Thursday it would restrict access to most public venues to immunized people only after coronavirus cases hit a record high in the Gulf ... Coronavirus